Neurobiology of DOPA as a Neurotransmitter - Image 1

£230.00

CRC Press Neurobiology of DOPA as a Neurotransmitter

Name: Neurobiology of DOPA as a Neurotransmitter
Brand: CRC Press
Price: 230.0 GBP
Availability: InStock

General Medical Issues

This is the most expensive it has ever been. Walk away.

£230 today · previous high £230 · all-time low £185

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 602 days • 602 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 602 days • 9 price levels

Days at Price

Current Price

Price Analysis

Most common price: £185 (231 days, 38.4%)

Price range: £185 - £230

Price levels: 9 different prices over 602 days

Description

New research suggests it is highly probable that DOPA, in addition to being a precursor to dopamine, functions by itself as a neurotramsmitter and/or neuromodulator. Neurobiology of DOPA as a Neurotransmitter integrates background information about DOPA as an inert amino acid precursor of dopamine with the evidence showing that DOPA fulfills several criteria of neurotransmitters. Providing easy access to, and complete understanding of, the latest research on the subject, the book makes the case that DOPA meets many of the criteria of neurotransmitters and includes anti-evidence in some instances. The book begins with a historical review of current knowledge of DOPA. It characterizes DOPA as a prominent example showing transmutation from an inert substance to a gold drug in Parkinson's disease and further to a neurotransmitter in its own right. The next chapters cover the essential criteria of a neurotransmitter such as synthesis, existence, and competitive antagonism. The book describes metabolism composed of catecholamine synthesis and degradation products related to neuron death, physiological release of DOPA in the lower brainstem, striatum, and nucleus accumbens, and physiological or pharmacological responses involved in baroreflex neurotransmission and related to behavioral science including interactions with catecholamines, acetylcholine, glutamate, and GABA. The book explores recognition sites, transport sites, and therapeutic role and mechanisms for neuron death related to adverse influence in the treatment of Parkinson's Disease. Edited by experts in the field, the breadth and depth of information contained in this book is confirmed by a quick scan of the chapter authors. They summarize the issues surrounding DOPA neurotoxicity and explore the link between experimental studies and clinical relevance.

Product Specifications

Brand: CRC Press
Format: Hardcover
ASIN: 0415332915
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > General Medical Issues
Domain: Amazon UK
Release Date: 01 November 2005
Listed Since: 09 February 2007

Barcode

No barcode data available

CRC Press Neurobiology of DOPA as a Neurotransmitter

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Advances in Neuropharmacology: Drugs and Therapeutics

Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models

Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)

Wiley Chemical Biology of Neurodegeneration - Molecular Approach

Dopaminergic Neuron Transplantation in the Weaver Mouse Model of Parkinson’s Disease: 517 (Advances in Experimental Medicine and Biology, 517)

Dopamine Receptor Technologies: 96 (Neuromethods, 96)

The Subthalamic Nucleus: Part II: Modelling and Simulation of Activity: 199 (Advances in Anatomy, Embryology and Cell Biology, 199)

Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

Parkinson's Disease: Molecular and Therapeutic Insights From Model Systems

Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)

Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

The Subthalamic Nucleus: Part I: Development, Cytology, Topography and Connections: 198 (Advances in Anatomy, Embryology and Cell Biology, 198)

Horizons in Neuroscience Research: Volume 37

Neurochemistry: Molecular and Cellular Clinical Applications

Neurotoxic Factors in Parkinson’s Disease and Related Disorders

Parkinson's Disease and Related Disorders, Part II (Volume 84) (Handbook of Clinical Neurology, Volume 84)

Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)

Dopamine (Volume 211) (Progress in Brain Research, Volume 211)

Parkinson's Disease and Movement Disorders

The Adenosinergic System: A Non-Dopaminergic Target in Parkinson’s Disease: 10 (Current Topics in Neurotoxicity, 10)

Parkinson's Disease and Related Disorders Part I (Volume 83) (Handbook of Clinical Neurology, Volume 83)

International Review of Neurobiology: Vol 54: Volume 54

Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders

The Neuroscience of Parkinson's Disease